Osteonecrose dos Maxilares Associada ao Uso de Bifosfonatos. Parte I: Etiologia e Apresentação Clínica

Ana Isabel Coelho1, Pedro de Sousa Gomes2, Maria Helena Fernandes3
1Médica Dentista, Faculdade de Medicina Dentária da Universidade do Porto
2Assistente da Faculdade de Medicina Dentária da Universidade do Porto
3Professora Catedrática da Faculdade de Medicina Dentária da Universidade do Porto

Tài liệu tham khảo

Bartl, 2007 Marx, 2003, Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic, J Oral Maxillofac Surg, 61, 1115, 10.1016/S0278-2391(03)00720-1 Ruggiero, 2004, Osteonecrosis of the jaws associated with the use of bisphosphonates: a review of 63 cases, J Oral Maxillofac Surg, 62, 527, 10.1016/j.joms.2004.02.004 Sarin, 2008, Updates on bisphosphonates and potential pathobiology of bisphosphonate-induced jaw osteonecrosis, Oral Dis, 14, 277, 10.1111/j.1601-0825.2007.01381.x Ruggiero, 2009, Bisphosphonate-related osteonecrosis of the jaw: diagnosis, prevention, and management, Annu Rev Med, 60, 85, 10.1146/annurev.med.60.063007.134350 Ruggiero, 2009, Bisphosphonate-related osteonecrosis of the jaw (BRONJ): initial discovery and subsequent development, J Oral Maxillofac Surg, 67, 13, 10.1016/j.joms.2008.10.005 Bagan, 2009, Osteonecrosis of the jaws in patients treated with intravenous bisphosphonates (BRONJ): A concise update, Oral Oncol, 45, 551, 10.1016/j.oraloncology.2009.01.002 Ruggiero, 2006, Practical Guidelines for the Prevention, Diagnosis, and Treatment of Osteonecrosis of the Jaw in Patients With Cancer, J Oncol Prac, 2, 7, 10.1200/JOP.2.1.7 Khosla, 2007, Bisphosphonate-associated osteonecrosis of the jaw: report of a task force of the American Society for Bone and Mineral Research, J Bone Miner Res, 22, 1479, 10.1359/jbmr.0707onj Khan, 2008, Canadian consensus practice guidelines for bisphosphonate associated osteonecrosis of the jaw, J Rheumatol, 35, 1391 Association, 2008 Rogers, 2000, Cellular and molecular mechanisms of action of bisphosphonates, Cancer, 88, 2961, 10.1002/1097-0142(20000615)88:12+<2961::AID-CNCR12>3.0.CO;2-L Wood, 2002, Novel antiangiogenic effects of the bisphosphonate compound zoledronic acid, J Pharmacol Exp Ther, 302, 1055, 10.1124/jpet.102.035295 Ruggiero, 2009, American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaws--2009 update, J Oral Maxillofac Surg, 67, 2 Sarasquete, 2009, Bisphosphonate-related osteonecrosis: genetic and acquired risk factors, Oral Dis, 15, 382, 10.1111/j.1601-0825.2009.01568.x